Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amita Gupta

Showing results (311-320 of 328) with videos related to

Pageof 33
Sort By:
Lancet (London, England)|March 31, 2016
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trialMina C Hosseinipour, Gregory P Bisson, Sachiko Miyahara, et al.
Plos One|May 24, 2019
Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPDAkshay N Gupte, Mandar Paradkar, Sriram Selvaraju, et al.
The European Respiratory Journal|August 10, 2021
Host lipidome and tuberculosis treatment failureRupak Shivakoti, John W Newman, Luke Elizabeth Hanna, et al.
Nature Communications|November 26, 2021
Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitorsCho Yeow Koh, Norrapat Shih, Christina Y C Yip, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2024
Factors Associated With Unfavorable Treatment Outcomes Among Persons With Pulmonary Tuberculosis: A Multicentric Prospective Cohort Study From IndiaSenbagavalli Prakash Babu, Komala Ezhumalai, Kalaivani Raghupathy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional StudyNishi Suryavanshi, Matthew Murrill, Amita Gupta, et al.
Chest|September 12, 2025
Contribution of Key Comorbidities to Unfavorable Treatment Outcomes Among Adults With Drug-Sensitive Pulmonary TB in India: A Prospective Cohort AnalysisPranay Sinha, Meagan Karoly, Chandrasekaran Padmapriyadarsini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis DiseaseAmita Gupta, Susan Swindells, Soyeon Kim, et al.
Plos One|July 30, 2020
Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in IndiaMandar Paradkar, Chandrasekaran Padmapriyadarsini, Divyashri Jain, et al.
Annals of Internal Medicine|September 22, 2020
Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort StudyBrian T Garibaldi, Jacob Fiksel, John Muschelli, et al.
Pageof 33

Showing results (311-320 of 328) with videos related to

Sort By:
Pageof 33
Lancet (London, England)|March 31, 2016
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trialMina C Hosseinipour, Gregory P Bisson, Sachiko Miyahara, et al.
Plos One|May 24, 2019
Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPDAkshay N Gupte, Mandar Paradkar, Sriram Selvaraju, et al.
The European Respiratory Journal|August 10, 2021
Host lipidome and tuberculosis treatment failureRupak Shivakoti, John W Newman, Luke Elizabeth Hanna, et al.
Nature Communications|November 26, 2021
Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitorsCho Yeow Koh, Norrapat Shih, Christina Y C Yip, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2024
Factors Associated With Unfavorable Treatment Outcomes Among Persons With Pulmonary Tuberculosis: A Multicentric Prospective Cohort Study From IndiaSenbagavalli Prakash Babu, Komala Ezhumalai, Kalaivani Raghupathy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional StudyNishi Suryavanshi, Matthew Murrill, Amita Gupta, et al.
Chest|September 12, 2025
Contribution of Key Comorbidities to Unfavorable Treatment Outcomes Among Adults With Drug-Sensitive Pulmonary TB in India: A Prospective Cohort AnalysisPranay Sinha, Meagan Karoly, Chandrasekaran Padmapriyadarsini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis DiseaseAmita Gupta, Susan Swindells, Soyeon Kim, et al.
Plos One|July 30, 2020
Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in IndiaMandar Paradkar, Chandrasekaran Padmapriyadarsini, Divyashri Jain, et al.
Annals of Internal Medicine|September 22, 2020
Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort StudyBrian T Garibaldi, Jacob Fiksel, John Muschelli, et al.
Pageof 33